Literature DB >> 9800635

Socioeconomic impact of otitis media in North America.

L M Elden1, P C Coyte.   

Abstract

OBJECTIVE: Otitis media (OM) is a common and expensive disease with estimated cost to the health care system in the U.S.A. estimated at 3 to 4 billion dollars and to that of Canada at 600 million dollars per year. Despite the high prevalence rates reported in North America, there remains little censensus about which of the various treatment strategies (medical or surgical) is most clinically effective, which is most cost effective, or which has the most economic and societal impact. Few studies have been conducted comparing the various treatment strategies or analyzing outcome measurement of physiologic end-points relative to the various treatments and quality-of-life issues. This article addresses these problem areas and gives recommendations and guidelines for consideration in the treatment of OM, as well as a review of the literature available.

Entities:  

Mesh:

Year:  1998        PMID: 9800635

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

1.  One hundred earaches. Family practice case series.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  2000-05       Impact factor: 3.275

2.  Essential Role of the Innate Immune Adaptor RIP2 in the Response to Otitis Media.

Authors:  Arwa Kurabi; Jasmine Lee; Kwang Pak; Anke Leichtle; Allen F Ryan
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

3.  Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media.

Authors:  Michael L Forbes; Edward Horsey; N Luisa Hiller; Farrel J Buchinsky; Jay D Hayes; James M Compliment; Todd Hillman; Suzanne Ezzo; Kai Shen; Randy Keefe; Karen Barbadora; J Christopher Post; Fen Ze Hu; Garth D Ehrlich
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

4.  A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media.

Authors:  Julia Noel; Keigo Suzukawa; Eduardo Chavez; Kwang Pak; Stephen I Wasserman; Arwa Kurabi; Allen F Ryan
Journal:  PLoS One       Date:  2020-08-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.